Akèy › Twoub Somnolans Eksestif › Ohio
Etid klinik pou Twoub Somnolans Eksestif nan Ohio
10 etid pou Twoub Somnolans Eksestif ap chèche patisipan nan sit nan Ohio.
Vil nan Ohio
Tèks ofisyèl etid la (Anglè)
A Study to Investigate the Effects of Cleminorexton Compared With Placebo in the Treatment of Participants With Central Disorders of Hypersomnolence
- Cincinnati, Ohio, Cincinnati
- Dublin, Ohio, Dublin
Ap rekriteFaz 2/3
Laj 18 a 70 · Tout sèks · Mizajou Oct 2, 2026 · NCT07598708A Phase 3 Efficacy and Safety Study of HBS-301 in Participants With Idiopathic Hypersomnia (IH)
- Neuroscience Research Center, LLC, Canton
- Intrepid Research, Cincinnati
Ap rekriteFaz 3
Laj 18 ak plis · Tout sèks · Mizajou Sep 14, 2026 · NCT07500090A Study to Evaluate the Efficacy and Safety of ALKS 2680 in Adults With Narcolepsy Type 1
- Alkermes Investigational Site, Cincinnati
Ap rekriteFaz 3
Laj 18 a 70 · Tout sèks · Mizajou Sep 3, 2026 · NCT07455383A Study to Evaluate the Efficacy and Safety of ALKS 2680 in Adults With Narcolepsy Type 2
- Alkermes Investigational Site, Cincinnati
Ap rekriteFaz 3
Laj 18 a 70 · Tout sèks · Mizajou Sep 3, 2026 · NCT07502443A Study to Evaluate the Efficacy, Safety and Tolerability of ALKS 2680 in Adults With Narcolepsy Type 1 (Brilliance NT1 - 304)
- Alkermes Investigational Site, Cincinnati
Ap rekriteFaz 3
Laj 18 a 70 · Tout sèks · Mizajou Sep 3, 2026 · NCT07540897A Study of Pitolisant in Patients With Prader-Willi Syndrome
- Center for Human Genetics, Cleveland
Ap rekriteFaz 3
Laj 6 ak plis · Tout sèks · Mizajou Aug 25, 2026 · NCT06366464A Long-Term Study of ALKS 2680 in Subjects With Narcolepsy and Idiopathic Hypersomnia
- Alkermes Investigational Site, Canton
- Alkermes Investigational Site, Cincinnati
- Alkermes Investigational Site, Cincinnati
- ak 1 plis
Ap rekriteFaz 2/3
Laj 18 a 70 · Tout sèks · Mizajou Aug 7, 2026 · NCT06767683Clinical Assessment of Response in the Treatment of Depression With Daytime Sleepiness Using Solriamfetol
- Clinical Research Site, Cincinnati
- Clinical Research Site, Cincinnati
Ap rekriteFaz 3
Laj 18 a 65 · Tout sèks · Mizajou Jul 24, 2026 · NCT07484217Studying Solriamfetol Modulation of TAAR-1, Dopamine, and Norepinephrine in Shift Work Disorder (SUSTAIN)
- Clinical Research Site, Cincinnati
- Clinical Research Site, Cincinnati
Ap rekriteFaz 3
Laj 18 a 65 · Tout sèks · Mizajou Jul 24, 2026 · NCT06568367A Long-term Extension Study of ORX750 in Participants With Narcolepsy and Idiopathic Hypersomnia
- Cincinnati, Ohio, Cincinnati
- Dublin, Dublin
Ap rekriteFaz 2
Laj 18 a 65 · Tout sèks · Mizajou Apr 16, 2026 · NCT07096674Sous ClinicalTrials.gov, done yo ranmase Oct 6, 2026. Chak etid gen kritè li pou li menm; ekip etid la deside ki moun ki ka patisipe.